# Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

> **NCT03026855** · PHASE1 · COMPLETED · sponsor: **TotipotentRX Cell Therapy Pvt. Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Chronic Ulcer

## Interventions

- **BIOLOGICAL:** Autologous PRP Gel and PRP Injection

## Key facts

- **NCT ID:** NCT03026855
- **Lead sponsor:** TotipotentRX Cell Therapy Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026855, "Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03026855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*